| Cluster 1 | Cluster 2 | Cluster 3 | P |
---|---|---|---|---|
Antithrombotic treatment | ||||
 Any antiplatelet, n (%) 9356 | 708 (19.5) | 304 (11.0) | 812 (27.5) | < .001 |
 Any OAC, n (%) 9359 | 3143 (86.5) | 2306 (83.2) | 2563 (86.7) | < .001 |
 Any VKA, n (%) 9358 | 1833 (50.5) | 1163 (42.0) | 1639 (55.5) | < .001 |
 Any NOAC, n (%) 9354 | 1314 (36.2) | 1145 (41.3) | 925 (31.3) | < .001 |
 Antithrombotic pattern, n (%) |  |  |  | < .001 |
  No antithrombotic | 217 (6.0) | 318 (11.5) | 142 (4.8) |  |
  Only antiplatelet | 273 (7.5) | 147 (5.3) | 250 (8.5) |  |
  Only VKA | 1524 (42.0) | 1059 (38.2) | 1228 (41.6) |  |
  Only NOAC | 1182 (32.6) | 1089 (39.3) | 773 (26.2) |  |
  Antiplatelet + OAC | 435 (12.0) | 157 (5.7) | 562 (19.0) |  |
Primary management (before admission) | Â | Â | Â | < .001 |
 Primary management strategy, n (%) 7753 |  |  |  | < .001 |
  Rate control | 1371 (45.3) | 802 (36.5) | 1317 (52.0) |  |
  Rhythm control | 1203 (39.8) | 1083 (49.3) | 852 (33.7) |  |
  Observation | 452 (14.9) | 311 (14.2) | 362 (14.3) |  |
 Primary ECV, n (%) 7350 | 693 (24.1) | 604 (28.5) | 476 (20.2) | < .001 |
 Primary PCV, n (%) 7281 | 730 (25.6) | 629 (29.9) | 621 (26.6) | .003 |
 Primary catheter ablation, n (%) 7531 | 171 (5.8) | 181 (8.4) | 108 (4.4) | < .001 |
Management during admission/consultation | Â | Â | Â | <.001 |
 Intervention planned/performed, n (%) 9363 | 1285 (34.6) | 1150 (41.5) | 984 (33.3) | <.001 |
 ECV, n (%) 3392 | 566 (45.0) | 628 (54.6) | 379 (38.5) | < .001 |
 PCV, n (%) 3392 | 304 (24.2) | 204 (17.7) | 245 (24.9) | < .001 |
 Catheter ablation, n (%) 3392 | 176 (14.0) | 261 (22.7) | 100 (10.2) | < .001 |
 Management strategy at discharge, n (%) |  |  |  | < .001 |
  Rate control | 1724 (47.5) | 984 (35.5) | 1522 (51.7) |  |
  Rhythm control | 1365 (37.6) | 1333 (48.1) | 981 (33.3) |  |
  Observation | 537 (14.8) | 452 (16.3) | 442 (15.0) |  |
 ABC pathway adherence, n (%) | 666 (30.8) | 655 (34.5) | 431 (26.2) | < .001 |